Investigational Drug Information for Hetrombopag
✉ Email this page to a colleague
What is the drug development status for Hetrombopag?
Hetrombopag is an investigational drug.
There have been 29 clinical trials for Hetrombopag.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2023.
The most common disease conditions in clinical trials are Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic, and Anemia, Aplastic. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Institute of Hematology & Blood Diseases Hospital, and Henan Cancer Hospital.
There are three US patents protecting this investigational drug and forty international patents.
Summary for Hetrombopag
| US Patents | 3 |
| International Patents | 40 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2023-04-01) |
| Vendors | 12 |
Recent Clinical Trials for Hetrombopag
| Title | Sponsor | Phase |
|---|---|---|
| Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors. | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) | Beijing Children's Hospital | Phase 4 |
| TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) | Henan Cancer Hospital | Phase 4 |
Clinical Trial Summary for Hetrombopag
Top disease conditions for Hetrombopag
Top clinical trial sponsors for Hetrombopag
US Patents for Hetrombopag
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hetrombopag | ⤷ Try a Trial | Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof | Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai, CN) | ⤷ Try a Trial |
| Hetrombopag | ⤷ Try a Trial | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN) | ⤷ Try a Trial |
| Hetrombopag | ⤷ Try a Trial | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hetrombopag
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Hetrombopag | Australia | AU2009207966 | 2028-01-10 | ⤷ Try a Trial |
| Hetrombopag | Brazil | BRPI0907234 | 2028-01-10 | ⤷ Try a Trial |
| Hetrombopag | Canada | CA2711535 | 2028-01-10 | ⤷ Try a Trial |
| Hetrombopag | China | CN101481352 | 2028-01-10 | ⤷ Try a Trial |
| Hetrombopag | China | CN101679286 | 2028-01-10 | ⤷ Try a Trial |
| Hetrombopag | European Patent Office | EP2236500 | 2028-01-10 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
